Dr. Gabriel Souza Vidal, MD

Dr. Vidal practices at Memorial Health System of Southwest Oklahoma in Lawton, Oklahoma, part of Memorial Health System of Southwest Oklahoma.

Dr. Vidal's NPI, 1487032116, was assigned on May 14, 2015. Dr. Vidal graduated from University of Oklahoma College of Medicine in 2015. Dr. Vidal holds Oklahoma license 31625.

Dr. Vidal's primary practice is Memorial Health System of Southwest Oklahoma, at 3401 West Gore Blvd, Lawton, OK 73505 in Comanche County. The practice phone is (580) 355-8620.

Dr. Vidal's primary practice is Memorial Health System of Southwest Oklahoma in Lawton, Oklahoma, part of Memorial Health System of Southwest Oklahoma. Dr. Vidal is also affiliated with OU Health University of Oklahoma Medical Center. The medical group on file is Cancer Centers of Southwest Oklahoma. Dmand AI also links Dr. Vidal to 3 more hospitals, 2 group practices and clinics, 2 medical groups and 1 community health center, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Vidal practices, 8 sites in all. Vendor and product names are available with a free account.

Radiation oncology is Dr. Vidal's primary specialty in the NPI Registry, under taxonomy code 2085R0001X. Dr. Vidal is licensed in Oklahoma.

CMS data shows 3,471 Medicare services from Dr. Vidal across 21 procedure codes in 2024, for 432 Medicare patients. Medicare paid $256,611 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 432 Medicare patients who saw Dr. Vidal in 2024. The largest group is 65 to 74, with 175 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 12% are also on Medicaid. Their average risk score is 2.04, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Vidal's median patient age at 71, with 45% women.

In 2024, Dr. Vidal wrote 167 Medicare Part D claims for 78 patients. 69% of them were for generic drugs. CMS names the drug for 63 of them, across 3 drugs with 11 or more claims each, at $866 in total drug cost. In 2016, CMS named 12 claims across 1 drug.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 82 out of 100 for Dr. Vidal for performance year 2024, reported as part of a group. Dr. Vidal accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Vidal as offering telehealth.

Removal of skin lesions: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 8 papers to Dr. Vidal, published from 2011 to 2025. 2025 was the busiest year, with 2. The most frequent topics are Radiation Oncology. Dr. Vidal has published most often in Int J Radiat Oncol Biol Phys. Dr. Vidal's most frequent co-authors are Avinash Chaurasia, MD, Judith A. James, MD, PhD and Amanda Rivera, MD.

CMS Open Payments shows 26 general payments to Dr. Vidal from 18 drug and device companies from 2017 to 2025. Food and beverage make up the largest share, 99% of the total. Novocure Inc. paid the most, $267.

Dr. Vidal graduated from University of Oklahoma College of Medicine in 2015.